Citation Impact

Citing Papers

Receptor-mediated low density lipoprotein catabolism in man.
1979
Lipoprotein Transport Gene Abnormalities Underlying Coronary Heart Disease Susceptibility
1991
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
1997 StandoutNobel
Beyond Cholesterol
1989 Standout
Regulation of the mevalonate pathway
1990 StandoutNature
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Apolipoprotein B: Structural and Metabolic Heterogeneity
1983
Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
1981
Discovery of the cellular and molecular basis of cholesterol control
2013 StandoutNobel
Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia
1985
Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1.
1988 StandoutNobel
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
1992 StandoutScience
Transfers and exchanges of esterified cholesterol between plasma lipoproteins
1982
Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.
1975
Suppression of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity and Inhibition of Growth of Human Fibroblasts by 7-Ketocholesterol
1974 StandoutNobel
Esterification of Low Density Lipoprotein Cholesterol in Human Fibroblasts and Its Absence in Homozygous Familial Hypercholesterolemia
1974 StandoutNobel
Regulation of the activity of the low density lipoprotein receptor in human fibroblasts
1975 StandoutNobel
Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts
1978
Genetics of the LDL receptor: Evidence that the mutations affecting binding and internalization are allelic
1977 StandoutNobel
Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.
1981
Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
1980
Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity
1974 StandoutNobel
Atherosclerosis: The low-density lipoprotein receptor hypothesis
1977 StandoutNobel
EVOLUTION OF THE LDL RECEPTOR CONCEPT–FROM CULTURED CELLS TO INTACT ANIMALS *
1980 StandoutNobel
Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients
1976
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.
1975 StandoutNobel
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
1975
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia
1982
Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia.
1978
Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein.
1975 StandoutNobel
The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptor
1983 StandoutNobel
Evidence for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat.
1976 StandoutNobel
Low density lipoprotein turnover in familial hypercholesterolaemia after plasma exchange
1976
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
The metabolism of the apoprotein of plasma low density lipoprotein in familial hype rbetalipoproteinaemia in the homozygous form
1975
The LDL Receptor Defect in Familial Hypercholesterolemia: Implications for Pathogenesis and Therapy
1982 StandoutNobel
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight.
1982 StandoutNobel
Abnormal induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in leukocytes from subjects with heterozygous familial hypercholesterolemia.
1975
Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol
1973 StandoutNobel
Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.
1982 StandoutNobel
Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia
1977
Therapeutic effects of ML-236B in primary hypercholesterolemia
1980
Antibody against low density lipoprotein receptor blocks uptake of low density lipoprotein (but not high density lipoprotein) by the adrenal gland of the mouse in vivo.
1981 StandoutNobel
Overloading human aortic smooth muscle cells with low density lipoprotein-cholesteryl esters reproduces features of atherosclerosis in vitro.
1977 StandoutNobel
Splanchnic Metabolism of Plasma Apolipoprotein B
1981
Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.
1994
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity in Cultured Human Fibroblasts
1974 StandoutNobel
Metabolic Studies in Familial Hypercholesterolemia
1979
Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans
1976 StandoutNobel
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
1983
Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cells
1975 StandoutNobel
Observations on the Passage of Apoproteins from Plasma Lipoproteins into Peripheral Lymph in Two Men
1975
Mutation in LDL Receptor: Alu-Alu Recombination Deletes Exons Encoding Transmembrane and Cytoplasmic Domains
1985 StandoutScienceNobel
Heterozygous familial hypercholesterolemia: Failure of normal allele to compensate for mutant allele at a regulated genetic locus
1976 StandoutNobel
Familial hypercholesterolemia
1975 StandoutNobel
Catabolism of the apoprotein of low density lipoproteins by the isolated perfused rat liver.
1978
Independent Pathways for Secretion of Cholesterol and Apolipoprotein E by Macrophages
1983 StandoutScienceNobel
Receptor-Mediated Control of Cholesterol Metabolism
1976 StandoutScienceNobel
Feedback Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Livers of Mice Treated with Mevinolin, a Competitive Inhibitor of the Reductase
1980 StandoutNobel
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors.
1980
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
1979 StandoutNobel
Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene.
1987 StandoutNobel
Assessment of long-term plasma exchange for familial hypercholesterolaemia.
1980
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
1981 StandoutNobel
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia.
1981 StandoutNobel
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
1981 StandoutNobel
Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in Man
1974 StandoutScienceNobel
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
1984 StandoutNobel
Receptor-mediated Catabolism of Low Density Lipoprotein in Man. QUANTITATION USING GLUCOSYLATED LOW DENSITY LIPOPROTEIN
1983
Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts
1974 StandoutNobel

Works of Terry Langer being referenced

Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
1987
Hypolipidemic Drugs and Lipoprotein Metabolism
1972
Genetic variation of human mononuclear leukocyte lysosomal acid lipase activity
1986
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
1972
Rankless by CCL
2026